These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 21636327)

  • 1. Lack of increased prevalence of immunoregulatory disorders in hereditary angioedema due to C1-inhibitor deficiency.
    Farkas H; Csuka D; Gács J; Czaller I; Zotter Z; Füst G; Varga L; Gergely P
    Clin Immunol; 2011 Oct; 141(1):58-66. PubMed ID: 21636327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physician- and patient-reported outcomes by hereditary angioedema type: Data from a real-world study.
    Anderson J; Soteres D; Mellor J; Connolly H; Wynne-Cattanach K; Earl L; Schultz BG; Juethner S
    Allergy Asthma Proc; 2024 Jul; 45(4):247-254. PubMed ID: 38982603
    [No Abstract]   [Full Text] [Related]  

  • 3. The CC2D2B is a novel genetic modifier of the clinical phenotype in patients with hereditary angioedema due to C1 inhibitor deficiency.
    Rupar N; Šelb J; Košnik M; Zidarn M; Andrejević S; Čulav L; Grivčeva-Panovska V; Korošec P; Rijavec M
    Gene; 2024 Aug; 919():148496. PubMed ID: 38679185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psychology and hereditary angioedema: A systematic review.
    Savarese L; Mormile I; Bova M; Petraroli A; Maiello A; Spadaro G; Freda MF
    Allergy Asthma Proc; 2021 Jan; 42(1):e1-e7. PubMed ID: 33404395
    [No Abstract]   [Full Text] [Related]  

  • 5. Exploring disease-specific metabolite signatures in hereditary angioedema patients.
    Kanepa A; Fan J; Rots D; Vaska A; Ansone L; Briviba M; Klovins J; Kurjane N; Klavins K
    Front Immunol; 2024; 15():1324671. PubMed ID: 38726011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complex analysis of the national Hereditary angioedema cohort in Slovakia - Identification of 12 novel variants in
    Markocsy A; Hrubiskova K; Hrubisko M; Freiberger T; Grombirikova H; Dolesova L; Slivka Vavrova L; Lohajova Behulova R; Ondrusova M; Banovcin P; Vorcakova K; Jesenak M
    World Allergy Organ J; 2024 Mar; 17(3):100885. PubMed ID: 38486718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Real-life Experience of Subcutaneous Plasma Derived C1-Inhibitor as Long-term Prophylaxis in HAE-C1INH.
    Entrala A; Loli-Ausejo D; Losantos I; Cabañas R; Caballero T
    J Investig Allergol Clin Immunol; 2024 Jul; 34(4):261-263. PubMed ID: 38131209
    [No Abstract]   [Full Text] [Related]  

  • 8. Long term outcome of C1-esterase inhibitor deficiency.
    Long LH; Fujioka T; Craig TJ; Hitomi H
    Asian Pac J Allergy Immunol; 2024 Jun; ():. PubMed ID: 38877850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of Complement and Contact System Activation via C1 Inhibitor Potentiation and Factor XIIa Activity Modulation by Sulfated Glycans - Structure-Activity Relationships.
    Schoenfeld AK; Lahrsen E; Alban S
    PLoS One; 2016; 11(10):e0165493. PubMed ID: 27783665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Population pharmacokinetics of recombinant human C1 inhibitor in patients with hereditary angioedema.
    Farrell C; Hayes S; Relan A; van Amersfoort ES; Pijpstra R; Hack CE
    Br J Clin Pharmacol; 2013 Dec; 76(6):897-907. PubMed ID: 23594263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Navigating the swells: A case report of hereditary angioedema.
    Taori K; Kirnake V; Junare P; Padwale V
    J Family Med Prim Care; 2024 Jul; 13(7):2784-2786. PubMed ID: 39071003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hereditary or acquired? Comprehensive genetic testing assists in stratifying angioedema patients.
    Rozevska M; Kanepa A; Purina S; Gailite L; Nartisa I; Farkas H; Rots D; Kurjane N
    Allergy Asthma Clin Immunol; 2024 Mar; 20(1):28. PubMed ID: 38555427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subcutaneous C1-Inhibitor Concentrate for prophylaxis during pregnancy and lactation in a patient with C1-INH-HAE.
    Andarawewa S; Aygören-Pürsün E
    Clin Case Rep; 2021 Mar; 9(3):1273-1275. PubMed ID: 33768824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 2010 International consensus algorithm for the diagnosis, therapy and management of hereditary angioedema.
    Bowen T; Cicardi M; Farkas H; Bork K; Longhurst HJ; Zuraw B; Aygoeren-Pürsün E; Craig T; Binkley K; Hebert J; Ritchie B; Bouillet L; Betschel S; Cogar D; Dean J; Devaraj R; Hamed A; Kamra P; Keith PK; Lacuesta G; Leith E; Lyons H; Mace S; Mako B; Neurath D; Poon MC; Rivard GE; Schellenberg R; Rowan D; Rowe A; Stark D; Sur S; Tsai E; Warrington R; Waserman S; Ameratunga R; Bernstein J; Björkander J; Brosz K; Brosz J; Bygum A; Caballero T; Frank M; Fust G; Harmat G; Kanani A; Kreuz W; Levi M; Li H; Martinez-Saguer I; Moldovan D; Nagy I; Nielsen EW; Nordenfelt P; Reshef A; Rusicke E; Smith-Foltz S; Späth P; Varga L; Xiang ZY
    Allergy Asthma Clin Immunol; 2010 Jul; 6(1):24. PubMed ID: 20667127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation of a suspicion index to identify patients at risk for hereditary angioedema.
    Shams M; Laney DA; Jacob DA; Yang J; Dronen J; Logue A; Rosen A; Riedl M
    J Allergy Clin Immunol Glob; 2023 Feb; 2(1):76-78. PubMed ID: 37780104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-Effectiveness of Prophylactic Medications for the Treatment of Hereditary Angioedema Due to C1 Inhibitor Deficiency: A Real-World U.S. Perspective.
    Zuraw BL
    J Manag Care Spec Pharm; 2019 Feb; 25(2):148-151. PubMed ID: 30698094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determinants of Disease Activity in Adults With Hereditary Angioedema due to C1-Esterase Inhibitor Deficiency.
    Lluncor-Salazar M; Phillips-Anglés E; Pedrosa M; Lamacchia D; Hernanz A; Prior N; Cabañas R; Caballero T
    J Investig Allergol Clin Immunol; 2024 Jul; ():0. PubMed ID: 39056466
    [No Abstract]   [Full Text] [Related]  

  • 18. Cardiovascular Autonomic Nervous System in a Patient With Hereditary Angioedema Affected by COVID-19.
    De Maria B; Parati M; Bey Y; Dalla Vecchia LA; Perego F
    Cureus; 2024 Mar; 16(3):e56449. PubMed ID: 38638792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selection of initiatives to improve the management of patients with hereditary angioedema by the hospital pharmacy using the nominal group technique.
    Montoro Ronsano JB; Martínez Sesmero JM; Cortés I; Lleonart R
    Eur J Hosp Pharm; 2024 Jun; ():. PubMed ID: 38844328
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.